CORONA logo

CORONA Remedies Limited Stock Price

NSEI:CORONA Community·₹95.7b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

CORONA Share Price Performance

₹1,581.40
143.00 (9.94%)
₹1,705.00
Fair Value
₹1,581.40
143.00 (9.94%)
7.2% undervalued intrinsic discount
₹1,705.00
Fair Value
Price ₹1,581.40
AnalystConsensusTarget ₹1,705.00

CORONA Community Narratives

AnalystConsensusTarget·
Fair Value ₹1.71k 7.2% undervalued intrinsic discount

Hormone Backward Integration And Women’s Health Portfolio Will Support Steady Long Term Prospects

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Trending Discussion

Updated Narratives

CORONA logo

Hormone Backward Integration And Women’s Health Portfolio Will Support Steady Long Term Prospects

Fair Value: ₹1.71k 7.2% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

High growth potential with solid track record.

0 Risks
2 Rewards

CORONA Remedies Limited Key Details

₹13.4b

Revenue

₹2.6b

Cost of Revenue

₹10.9b

Gross Profit

₹9.1b

Other Expenses

₹1.7b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
28.02
80.79%
12.75%
9.5%
View Full Analysis

About CORONA

Founded
2004
Employees
4500
CEO
Niravkumar Mehta
WebsiteView website
www.coronaremedies.com

CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women’s healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.